Skip to main content
. 2023 Mar 24;13(1):38–43. doi: 10.4103/ijciis.ijciis_20_22

Table 1.

Common obstetric medications and treatments

Condition Diagnostic assessment Medication or treatment
PPH Fundal check for uterine tone Rapid bedside ultrasound or pelvic exam for retained products Laboratory evaluation for DIC or coagulation defect Atony: Uterotonics: Oxytocin, misoprostol, methergine, carboprost Antifibrinolytics: TXA 1 g IV Uterine tamponade: Balloon or vacuum device Surgical intervention
Antepartum hemorrhage Evaluation for abnormal placentation Clinical signs of placental abruption (painful contractions, vaginal bleeding, nonreassuring fetal heart tracing) Evaluation of Rh status Consideration for delivery Rhogam administration pending clinical scenario
Preeclampsia Evaluation of blood pressure (elevated 140/90, severe 160/110) Evaluation for proteinuria Evaluation for thrombocytopenia, transaminitis, renal insufficiency, pulmonary edema, or clinical signs Treatment of severe blood pressures within 15 min: IV labetalol, hydralazine, PO nifedipine, or nicardipine or sodium nitroprusside Prevention of seizures
Eclampsia New-onset seizures in a patient with preeclampsia Usually self-limiting Magnesium 4 g or 6g IV loading dose with 2 g/h continuous to prevent further seizures
Amniotic fluid embolus Cardiorespiratory arrest or compromise and DIC at time of labor Supportive ACLS, with MTP and fluid support A OK regimen (anecdotal): 1 mg atropine, 8 mg ondansetron, 15 mg ketorolac
Sepsis Evaluation for cause, including endometritis or chorioamnionitis on differential Surviving sepsis treatment Ampicillin/gentamicin for chorioamnionitis Ampicillin/gentamicin/metronidazole for endometritis

DIC: Disseminated intravascular coagulation, TXA: Tranexamic acid, MTP: Massive transfusion protocol, PPH: Postpartum hemorrhage, IV: Intravenous, ACLS: Advanced cardiac life support, PO: Per os